JNJ Johnson & Johnson
- 145.650
- -0.300-0.21%
- 145.650
- 0.0000.00%
Johnson & Johnson News
Johnson & Johnson | 4: Statement of changes in beneficial ownership of securities-Director Woods Eugene A.
Johnson & Johnson | 4: Statement of changes in beneficial ownership of securities-Director HEWSON MARILLYN A
Johnson & Johnson | SD: Specialized disclosure report
Johnson & Johnson | CERT: Others
Johnson & Johnson | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Johnson & Johnson(-0-%)
Johnson & Johnson | 8-A12B: Registration of a class of securities on a national securities exchange
Johnson & Johnson | 8-K: Johnson & Johnson Signed Underwriting Agreements for Issuing U.S. Dollar and Euro Notes
Johnson & Johnson | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Johnson & Johnson | 8-K: Johnson & Johnson Completed an Exchange of Kenvue Common Stock for the Outstanding Commercial Paper
Johnson & Johnson | 424B2: Prospectus
Johnson & Johnson | 424B2: Prospectus
Johnson & Johnson | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Johnson & Johnson | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Johnson & Johnson | 424B5: Prospectus
Johnson & Johnson | 424B5: Prospectus
Johnson & Johnson | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)
Johnson & Johnson | 4: Statement of changes in beneficial ownership of securities-Officer REED JOHN C
Johnson & Johnson | 10-Q: Quarterly report
Johnson & Johnson | 8-K: Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
Johnson & Johnson | 4: Statement of changes in beneficial ownership of securities-Director Beckerle Mary C
Analysis
Price Target
No Data
